Alpinetin inhibits lipopolysaccharide-induced acute kidney injury in mice

International Immunopharmacology

Volumn 28, Issue 2, 2015, Pages 1003-1008

  Huang, Yi ^a   Zhou, Li shan ^b   Yan, Li ^a   Ren, Juan ^a   Zhou, Dai xing ^a   Li, Shu Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Children's Hospital of Wuhan   (China)

Author keywords

Acute kidney injury; Alpinetin; LPS; NF B; Nrf2

Indexed keywords

ALPINETIN; CREATININE; FLAVONOID; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; URINARY TRACT AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FLAVANONE DERIVATIVE; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ACUTE KIDNEY INJURY; ALPINIA; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY;

ACUTE KIDNEY INJURY; ALPINIA; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; FLAVANONES; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HUMANS; INTERLEUKIN-1BETA; KIDNEY; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NF-E2-RELATED FACTOR 2; NF-KAPPA B; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940063026     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.08.002     Document Type: Article

References (29)

1. [1] Kox, W.J., Volk, T., Kox, S.N., Volk, H.D., Immunomodulatory therapies in sepsis. Intensive Care Med. 26:Suppl. 1 (2000), S124–S128.
2. [2] Lameire, N.H., Bagga, A., Cruz, D., De Maeseneer, J., Endre, Z., Kellum, J.A., et al. Acute kidney injury: an increasing global concern. Lancet 382 (2013), 170–179.
3. [3] Badr, K.F., Kelley, V.E., Rennke, H.G., Brenner, B.M., Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int. 30 (1986), 474–480.
4. [4] Gupta, A., Rhodes, G.J., Berg, D.T., Gerlitz, B., Molitoris, B.A., Grinnell, B.W., Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am. J. Physiol. Renal Physiol. 293 (2007), F245–F254.
5. [5] Wang, W., Bansal, S., Falk, S., Ljubanovic, D., Schrier, R., Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am. J. Physiol. Ren. Physiol. 297 (2009), F1032–F1037.
6. [6] Castoldi, A., Braga, T.T., Correa-Costa, M., Aguiar, C.F., Bassi, E.J., Correa-Silva, R., et al. TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis. Plos One, 7, 2012.
7. [7] Ramesh, G., Reeves, W.B., TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110 (2002), 835–842.
8. [8] Li, P.K.T., Burdmann, E.A., Mehta, R.L., Steering, W.K.D., Acute kidney injury: global health alert. Curr. Opin. Nephrol. Hypertens. 22 (2013), 253–258.
9. [9] Selby, N.M., Crowley, L., Fluck, R.J., McIntyre, C.W., Monaghan, J., Lawson, N., et al. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin. J. Am. Soc. Nephrol. 7 (2012), 533–540.
10. [10] He, W.Y., Li, Y., Xue, C.X., Hu, Z.D., Chen, X.G., Sheng, F.L., Effect of Chinese medicine alpinetin on the structure of human serum albumin. Bioorg. Med. Chem. 13 (2005), 1837–1845.
11. [11] Li, Y.J., Du, G.H., Effects of alpinetin on rat vascular smooth muscle cells. J. Asian Nat. Prod. Res. 6 (2004), 87–92.
12. [12] Huo, M.X., Chen, N., Chi, G.F., Yuan, X., Guan, S., Li, H.Y., et al. Traditional medicine alpinetin inhibits the inflammatory response in raw 264.7 cells and mouse models. Int. Immunopharmacol. 12 (2012), 241–248.
13. [13] Hu, K., Yang, Y., Tu, Q.Y., Luo, Y.Q., Ma, R.T., Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-gamma in THP-1-derived macrophages. Eur. J. Pharmacol. 721 (2013), 96–102.
14. [14] Chen, H.J., Mo, X.D., Yu, J.L., Huang, Z.H., Alpinetin attenuates inflammatory responses by interfering toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced mastitis in mice. Int. Immunopharmacol. 17 (2013), 26–32.
15. [15] Shinomol, G.K., Muralidhara, Differential induction of oxidative impairments in brain regions of male mice following subchronic consumption of Khesari dhal (Lathyrus sativus) and detoxified Khesari dhal. Neurotoxicology 28 (2007), 798–806.
16. [16] Bonventre, J.V., Pathophysiology of AKI: injury and normal and abnormal repair. Contrib. Nephrol. 165 (2010), 9–17.
17. [17] Miyazaki, H., Morishita, J., Ueki, M., Nishina, K., Shiozawa, S., Maekawa, N., The effects of a selective inhibitor of c-Fos/activator protein-1 on endotoxin-induced acute kidney injury in mice. BMC Nephrol., 13, 2012, 153.
18. [18] Xu, D., Chen, M., Ren, X., Ren, X., Wu, Y., Leonurine ameliorates LPS-induced acute kidney injury via suppressing ROS-mediated NF-kappaB signaling pathway. Fitoterapia 97 (2014), 148–155.
19. [19] Sarady-Andrews, J.K., Liu, F., Gallo, D., Nakao, A., Overhaus, M., Ollinger, R., et al. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005), L1131–L1137.
20. [20] Blackwell, T.S., Christman, J.W., The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17 (1997), 3–9.
21. [21] Vallabhapurapu, S., Karin, M., Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27 (2009), 693–733.
22. [22] Zhang, C.J., Walker, L.M., Mayeux, P.R., Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney. Biochem. Pharmacol. 59 (2000), 203–209.
23. [23] Agarwal, R., Campbell, R.C., Warnock, D.G., Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Semin. Nephrol. 24 (2004), 101–114.
24. [24] Kim, S.J., Gil, H.W., Yang, J.O., Lee, E.Y., Hong, S.Y., The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol. Dial. Transplant. 24 (2009), 1226–1232.
25. [25] Liu, C.M., Sun, Y.Z., Sun, J.M., Ma, J.Q., Cheng, C., Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-kappa B pathway. Biochim. Biophys. Acta Gen. Subj. 2012 (1820), 1693–1703.
26. [26] Liu, J., Yeo, H.C., Overvik-Douki, E., Hagen, T., Doniger, S.J., Chyu, D.W., et al. Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J. Appl. Physiol. 89 (2000), 21–28.
27. [27] Jaiswal, A.K., Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36 (2004), 1199–1207.
28. [28] He, M., Siow, R.C.M., Sugden, D., Gao, L., Cheng, X., Mann, G.E., Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutr. Metab. Cardiovasc. Dis. 21 (2011), 277–285.
29. [29] Liu, M., Grigoryev, D.N., Crow, M.T., Haas, M., Yamamoto, M., Reddy, S.P., et al. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int. 76 (2009), 277–285.